NORA-HOME: An Ambulatory Multimodal Monitoring Model In Patients With Minor Stroke And Transient Ischemic Attacks

Condition(s) studied

Investigational drug(s) / intervention(s)

Home hospitalization: patients randomized to the treatment group (NORAHOME) to validate that our Home Hospitalization program for patients with TIA or minor stroke

Study summary

In this project, we aim to validate a Home Hospitalization plan for patients with TIA or minor stroke. Our hypothesis is that our Multimodal Home Hospitalization program (NORAHOME) for patients with TIA and minor stroke is safe, reduces the complications associated with conventional hospitalization, and is more efficient than Standard Clinical Practice. To conduct the study, we require the voluntary participation of patients with TIA and minor strokes.

Eligibility

Primary outcome measure(s)

• Primary efficacy objective — 3months
  Change in the rate of early recurrence and hospital readmission compared to standard clinical practice.
• Primary efficacy objective — 3 months
  Change in the rate of early recurrence and hospital readmission compared to standard clinical practice.
• Primary safety objective — 3months
  Change in the number of complications (falls, recurrences, infections) in patients with TIA/minor stroke compared to standard clinical practice.

Trial sites (1)

More Hospital Universitari Vall d'Hebron Research Institute trials in Spain

Other trials for the same condition